Sponsor:
Rockefeller University
Code:
NCT00230165
Conditions
Glanzmann Thrombasthenia
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Glanzmann Thrombasthenia
Study ID
NCT00230165
Start date
Sep, 2005
Status verified date
Oct, 2025
Completion date
Jun, 2030
Anticipated
Primary completion date
Jun, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Arms
Normal
Glanzmann thrombasthenia
Primary outcome measure
Central contacts
Locations
Rockefeller University Hospital
Recruiting
New York, New York, United States, 10021
Contacts
Principal Investigator:
Barry Coller, MD
Sponsor
Rockefeller University
Last update posted
Oct 20, 2025
Last verified
Oct, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Rockefeller University on 2025-10-20.